David Cortez named associate director of basic science research at VICC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

David Cortez was named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center.

Cortez, the Richard Armstrong Professor of Biochemistry, joined Vanderbilt University in 2002. He is an expert in the field of DNA damage response and repair and made seminal discoveries about the mechanisms that maintain genome integrity.

Cortez is a member of the editorial boards for Cell Reports and Molecular and Cellular Biology. Cortez has been a co-leader of the Genome Maintenance Research Program since its inception in 2007 at VICC, and served as director of Graduate Studies in the Department of Biochemistry at Vanderbilt University for eight years.

Cortez replaces Scott Hiebert, professor of biochemistry and Hortense B. Ingram Professor of Cancer Research, who has served in the role since 2008. Hiebert is a member of the National Cancer Advisory Board.

Hiebert will continue in his role as associate director for shared resources and another interim leadership role to be announced soon. He will continue to focus on the molecular mechanisms of acute leukemia and the action of tumor suppressors in his own research program.

Table of Contents

YOU MAY BE INTERESTED IN

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login